4//SEC Filing
Raythatha Jigar 4
Accession 0001640455-21-000137
CIK 0001640455other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 8:16 AM ET
Size
5.3 KB
Accession
0001640455-21-000137
Insider Transaction Report
Form 4
Raythatha Jigar
Director
Transactions
- Award
Common Stock
2021-09-13+31,400→ 31,400 totalExercise: $6.47Exp: 2031-09-13→ Common Stock (31,400 underlying)
Footnotes (1)
- [F1]The option was granted on September 13, 2021 and will vest in equal quarterly installments during the twelve quarters following the grant date, subject the to Reporting Person's continued service as a director.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001745787
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 8:16 AM ET
- Size
- 5.3 KB